Skip to content
    Drishti.money
    Earnings calls

    Acutaas Chemical concall ledger

    Every earnings call for ACUTAAS — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    ACUTAAS · 5 transcripts · Healthcare · latest Q4 FY26
    Q4 FY26Published 30 Apr 2026Call held 30 Apr 2026

    ACUTAAS Q4 FY26 Earnings Call Transcript & Analysis

    Revenue₹432.8 cr+40% YoYEBITDA₹183.5 cr+100% YoYEBITDA Margin42.4%PAT₹134.3 cr+114% YoYPAT Margin31%

    Revenue (Q4 FY26) ₹433 cr (+40% YoY); EBITDA (Q4 FY26) ₹184 cr (+100% YoY); EBITDA Margin (Q4 FY26) 42.4%. Revenue from operations for Q4 FY26 reached INR 432.8 crores, representing 40.3% growth Y-o-Y.

    Read full transcript & analysis
    Q3 FY26Published 28 Jan 2026Call held 28 Jan 2026

    ACUTAAS Q3 FY26 Earnings Call Transcript & Analysis

    Revenue from Operations₹393.2 cr+43% YoYEBITDA₹150.7 cr+100% YoYEBITDA Margin38.3%PAT₹106.2 cr+134% YoYPAT Margin27%

    Revenue from Operations (Q3 FY26) ₹393 cr (+43% YoY); EBITDA (Q3 FY26) ₹151 cr (+100% YoY); EBITDA Margin (Q3 FY26) 38.3%. Revenue from operations reached INR393.2 crores, up 43% YoY.

    Read full transcript & analysis
    Q4 FY25Published 02 May 2025Call held 02 May 2025

    ACUTAAS Q4 FY25 Earnings Call Transcript & Analysis

    Revenue₹308.5 cr+37% YoYEBITDA₹85 cr+99% YoYEBITDA Margin27.5%+8% YoYPAT₹62.7 cr+144% YoYPAT Margin20.3%+9% YoY

    Revenue (Q4 FY25) ₹308 cr (+37% YoY); EBITDA (Q4 FY25) ₹85 cr (+99% YoY); EBITDA Margin (Q4 FY25) 27.5% (+8% YoY). FY25 Revenue crossed INR1,000 crore threshold, reaching INR1,006.9 crores, up 40.3% YoY.

    Read full transcript & analysis